Why is Jubilant Pharmo falling/rising?

As of 02-Jul, Jubilant Pharmova Ltd's stock price is currently at 1,198.95, reflecting an increase of 2.9, or 0.24%. The stock is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend. Despite a significant drop in delivery volume by 46.38% against the 5-day average, the company has shown strong performance metrics, including a 25.02% growth in operating profit and positive results for the last seven consecutive quarters. With a return of 62.36% over the past year and a PEG ratio of 0.4, the stock is considered attractively valued compared to its peers, bolstered by high institutional holdings at 24.27%.
In the broader market context, Jubilant Pharmova's short-term return of 1.28% over the past week outpaces the Sensex's return of 0.79%, reflecting its strong performance relative to the benchmark. The stock has also outperformed the BSE500 over various time frames, indicating robust market confidence. Overall, the combination of solid financial results, attractive valuations, and institutional backing contributes to the stock's rising price, despite the recent decline in investor participation.